Chinese National Human Genome Center

Chinese National Human Genome Center

Chinese National Human Genome Center, Beijing , was established as one of the national-level genome research center approved by the Ministry of Science & Technology. CHGB promotes the commercialization of research products and initiate genome industry in China. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Chinese National Human Genome Center, China, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

64%


Total
Publications

837


Total Open
Publications

536


Total
Citations

65K


Open Access
Percentage

64%


Total
Publications

837


Total Open
Publications

536


Total
Citations

65K

Wikipedia

Website

download

Breakdown

16% 41% 7% 36%

Publisher Open

16%

Both

41%

Other Platform Open

7%

Closed

36%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0510152025303540455055Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

50%OA Journal

OA Journal 50%

236

Hybrid 21%

102

No Guarantees 29%

138

Other Platform Open

Domain 93%

375

Public 21%

86

Institution 7%

29

Other Internet 5%

21

Preprint 5%

19

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
376
Europe PMC
Domain
249
Semantic Scholar
Public
78
Figshare
Public
26
DOI
Other Internet
14
University of Dundee - Discovery Research Portal
Institution
13
University of Bristol - Bristol Research
Institution
13
Research Square
Preprint
10
University of North Carolina at Chapel Hill - Carolina Digital Repository
Institution
8
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
8
1 / 7

Data updated 7 October 2024

Share

Share

Share